Financial Incentives to Exercise for Adolescents (MOVE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01848353 |
Recruitment Status :
Completed
First Posted : May 7, 2013
Results First Posted : March 14, 2019
Last Update Posted : April 3, 2019
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Other |
Conditions |
Insulin Resistance Obesity Sedentary Lifestyle |
Intervention |
Behavioral: Exercise training |
Enrollment | 142 |
Recruitment Details | Recruitment for the exercise intervention was July 2013 - April 2016. Recruitment for the reference group was July 2015 - April 2017. All participants were were recruited from medical clinics, schools, or community settings in Southeast Oklahoma. |
Pre-assignment Details | 142 people enrolled (completed informed consent). During screening, 4 OW/Ob and 8 NW people were disqualified, and 5 OW/Ob and 5 NW people voluntarily withdrew. Baseline data were thus available for 120 people. After baseline testing was complete, 81 OW/Ob participants were randomly assigned to either standard pay or incentive group for Phase 1. |
Arm/Group Title | Standard Payment | Incentivized Payment | Normal Weight, Low Activity Group | Normal Weight, High Activity Group |
---|---|---|---|---|
![]() |
All participants will perform exercise training. Participants in this arm will receive a fixed amount of money for exercise session lasting at least 20 minutes. All exercise recommendations and outcome tests will be same for this group as the experimental group so that the two groups differ only in the financial incentives they receive for exercise behavior. Exercise training: All participants will perform exercise training at the wellness center. Exercise duration and intensity will be recorded with heart rate monitors. |
All participants will perform exercise training. Participants in this arm will receive an increasing amount of money when they increase exercise frequency (number of days) during weeks 1-16 (phase 1), or increase exercise duration (minutes per session) during weeks 17-32 (phase 2). In phase 3 the payment will be a lottery, with the number of lottery chances based on exercise frequency and duration. All exercise recommendations and outcome tests will be same for this group as the active comparator group so that the two groups differ only in the financial incentives they receive for exercise behavior Exercise training: All participants will perform exercise training at the wellness center. Exercise duration and intensity will be recorded with heart rate monitors. |
This group of participants will complete only the baseline tests and assessments and will serve as a reference group. They will be selected to have low physical activity and fitness like the intervention group. Therefore differences in their results with the intervention group will reflect the effects of overweight/obesity on the variables of interest. | This group of participants will complete only the baseline tests and assessments and will serve as a reference group. They will be selected to have higher physical activity and fitness than the intervention group. They will therefore serve as a healthy reference group and differences in their results with the intervention group will reflect the effects of both overweight/obesity and physical activity on the variables of interest. |
Period Title: Phase 1 | ||||
Started | 38 | 43 | 20 | 19 |
Completed | 35 | 42 | 20 | 19 |
Not Completed | 3 | 1 | 0 | 0 |
Reason Not Completed | ||||
Withdrawal by Subject | 3 | 1 | 0 | 0 |
Period Title: Phase 2 | ||||
Started | 23 [1] | 28 [1] | 0 [2] | 0 [2] |
Completed | 20 | 26 | 0 | 0 |
Not Completed | 3 | 2 | 0 | 0 |
Reason Not Completed | ||||
Withdrawal by Subject | 3 | 2 | 0 | 0 |
[1]
26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2
[2]
Normal weight participants only completed baseline testing in Phase 1.
|
||||
Period Title: Phase 3 | ||||
Started | 5 [1] | 10 [1] | 0 [2] | 0 [2] |
Completed | 4 | 9 | 0 | 0 |
Not Completed | 1 | 1 | 0 | 0 |
Reason Not Completed | ||||
Withdrawal by Subject | 1 | 1 | 0 | 0 |
[1]
31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3
[2]
Normal weight participants only completed baseline testing in Phase 1.
|
Arm/Group Title | Standard Payment, Phase 1 | Incentivized Payment, Phase 1 | Normal Weight, Low Activity Group | Normal Weight, High Activity Group | Total | |
---|---|---|---|---|---|---|
![]() |
All participants will perform exercise training. Participants in this arm will receive a fixed amount of money for exercise session lasting at least 20 minutes during weeks 1-16 (phase 1). All exercise recommendations and outcome tests will be same for this group as the experimental group so that the two groups differ only in the financial incentives they receive for exercise behavior. Exercise training: All participants will perform exercise training at the wellness center. Exercise duration and intensity will be recorded with heart rate monitors. |
All participants will perform exercise training. Participants in this arm will receive an increasing amount of money when they increase exercise frequency (number of days) during weeks 1-16 (phase 1). All exercise recommendations and outcome tests will be same for this group as the active comparator group so that the two groups differ only in the financial incentives they receive for exercise behavior Exercise training: All participants will perform exercise training at the wellness center. Exercise duration and intensity will be recorded with heart rate monitors. |
This group of participants will complete only the baseline tests and assessments and will serve as a reference group. They will be selected to have low physical activity and fitness like the intervention group. Therefore differences in their results with the intervention group will reflect the effects of overweight/obesity on the variables of interest. | This group of participants will complete only the baseline tests and assessments and will serve as a reference group. They will be selected to have higher physical activity and fitness than the intervention group. They will therefore serve as a healthy reference group and differences in their results with the intervention group will reflect the effects of both overweight/obesity and physical activity on the variables of interest. | Total of all reporting groups | |
Overall Number of Baseline Participants | 38 | 43 | 20 | 19 | 120 | |
![]() |
Normal weight groups completed only the baseline testing. The overweight/obese group entered the exercise program at phase 1, and then continued on to phases 2 and 3 if they remained enrolled.
|
|||||
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
||||||
Number Analyzed | 38 participants | 43 participants | 20 participants | 19 participants | 120 participants | |
13.8 (2.2) | 14.2 (2.2) | 14.6 (2.3) | 14.3 (1.9) | 14.4 (2.3) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||||||
Number Analyzed | 38 participants | 43 participants | 20 participants | 19 participants | 120 participants | |
Female |
21 55.3%
|
25 58.1%
|
11 55.0%
|
7 36.8%
|
64 53.3%
|
|
Male |
17 44.7%
|
18 41.9%
|
9 45.0%
|
12 63.2%
|
56 46.7%
|
|
Race (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||||||
Number Analyzed | 38 participants | 43 participants | 20 participants | 19 participants | 120 participants | |
American Indian or Alaska Native |
38 100.0%
|
43 100.0%
|
20 100.0%
|
19 100.0%
|
120 100.0%
|
|
Asian |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Native Hawaiian or Other Pacific Islander |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Black or African American |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
White |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
More than one race |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Unknown or Not Reported |
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||||||
United States | Number Analyzed | 38 participants | 43 participants | 20 participants | 19 participants | 120 participants |
38 | 43 | 20 | 19 | 186 | ||
Body mass index
Mean (Standard Deviation) Unit of measure: Kg/m^2 |
||||||
Number Analyzed | 38 participants | 43 participants | 20 participants | 19 participants | 120 participants | |
33.4 (7.0) | 34.8 (6.1) | 20.8 (1.9) | 20.1 (2.4) | 30.1 (9.0) |
Name/Title: | Kevin Short, PhD, Associate Professor |
Organization: | University of Oklahoma Health Sciences Center |
Phone: | (405) 271-8001 ext 43094 |
EMail: | kevin-short@ouhsc.edu |
Responsible Party: | University of Oklahoma |
ClinicalTrials.gov Identifier: | NCT01848353 |
Other Study ID Numbers: |
P20 MD000528-RP2 |
First Submitted: | April 25, 2013 |
First Posted: | May 7, 2013 |
Results First Submitted: | April 10, 2018 |
Results First Posted: | March 14, 2019 |
Last Update Posted: | April 3, 2019 |